Over 80% of assessed basal cell carcinoma lesions regressed across three Gorlin syndrome patients treated with KB113Substantial regression was ...
In Healthcare Innovation interview, CEO Anu Sharma says partnership with El Camino follows Millie joining UCSF Health’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results